45味中药乙醇提取物中对酪氨酸酶的激活作用

从中医治疗白癜风方剂中筛选出中药45味,观察这些中药50%乙醇提取物对蘑菇酪氨酸酶和无细胞系统多巴色素自动氧化生成黑素量的影响.结果显示有21味中药乙醇提取物在3个不同浓度对蘑菇酪氨酸酶活性、黑素生成具有激活作用,其中女贞子、梅花和八角茴香对酪氨酸酶的激活作用较明显;同时分析了其中有激活作用的中药的功用等分类情况,以探...     

葛根提取物对酪氨酸酶活性的影响

研究了葛根不同提取物对酪氨酸酶活性的影响,结果表明:葛根水提物及乙醇提取物在60 mg/mL时对酪氨酸酶的激活作用最强,激活率分别为101.4%和137.7%.两者对酪氨酸酶的激活作用与其葛根素含量无明显相关性.葛根水提物及醇提物能使酪氨酸酶对底物结合的亲和力明显增强(Km/Km′=5.89,Km/Km″=6.43),同时使最大酶促反应速度有了明显提高(Vm′/Vm=2.088,Vm″/Vm=2.354),两者的激活作用都表现为混合型.     

驱虫斑鸠菊对B-16黑素瘤细胞酪氨酸酶活性及黑素生成影响

目的 :探讨驱虫斑鸠菊体外对酪氨酸酶活性影响 ,以及对小鼠B - 16黑素瘤细胞株细胞增殖、黑素合成以及细胞内酪氨酸酶的作用。方法 :利用四甲基偶氮唑蓝 (MTT)比色法测定药物对细胞增殖的影响 ;采用酶学方法研究药物对酪氨酸酶活性的影响 ;470nm比色法测定黑素含量。结果驱虫斑鸠菊体外可激活酪氨酸酶活性 ,增强B - 16鼠黑素瘤细胞增殖 ,提高酪氨酸酶和黑色素合成能力 ;对整体动物黑素细胞具有促进合成和分泌作用。结论在白癜风的治疗中 ,驱虫斑鸠菊可增强酪氨酸酶活性 ,进而促进黑素合成     

香樟酪氨酸酶对NAA诱导的响应及其生化性质研究

以离体香樟叶片和果实为材料,研究了萘乙酸(NAA)处理对其中酪氨酸酶及其同工酶活性的影响,并对香樟果实中酪氨酸酶进行分离纯化,初步分析了该酶基本生化特征.结果表明:(1)10μmol·L-1NAA处理对香樟叶片同工酶TYRL2有较强的激活作用,对同工酶TYRL1有抑制作用,1.0和0.1μmol·L-1浓度的NAA对同工酶TYRL3有激活作用;(2)在香樟果实的酪氨酸酶同工酶中,TYRF1的活性最高并在果实成熟过程中逐渐增强,100μmol·L-1的NAA对果实成熟以及酪氨酸酶的酶活性都有一定的促进作用;(3)经纯化的香樟果实酪氨酸酶最适pH值为7.5,最适温度为50℃,亚基分子量为43KDa;以L-DOPA为底物时的Km为12.82mmol·L-1,Vmax为80.65U·mg-1蛋白;其在酸性(pH4~7)和高温(40~70℃)条件下较稳定.可见,不同浓度的NAA对香樟叶片和果实中的酪氨酸酶活性有不同程度的激活和抑制作用.     

制何首乌提取物及主要单体成分对细胞酪氨酸酶及抗氧化保护作用研究

为了探究制何首乌发挥乌发功效的机制,我们利用多巴速率氧化法、多巴染色法评价制何首乌水提物(PWE)、粗多糖及二苯乙烯苷、大黄素对B16F10中酪氨酸酶活性的影响,并利用实时荧光定量PCR法检测其对细胞酪氨酸酶mRNA表达量的影响。结果显示,受试药物对B16F10内酪氨酸酶活性无明显激活作用,但500μg/m L的PWE可显著激活酪氨酸酶mRNA表达;另一方面,利用DPPH自由基清除法测定PWE及大黄素、二苯乙烯苷的体外抗氧化能力,并利用Hep G2C8细胞模型考察其在细胞水平上的抗氧化能力,结果发现,PWE及二苯乙烯苷体外可浓度依赖地清除DPPH自由基,且能激活模型细胞Hep G2C8中ARE的表达,表明二者具有显著的抗氧化活性,或为制何首乌乌发作用要因。     

补骨脂素对乳鼠颅骨成骨细胞分化成熟的影响

骨质疏松症是一种全身性骨骼疾病,其特点是骨量低、骨微结构恶化、骨脆性增加、易骨折。为了改善骨质疏松,需要寻找合成代谢和口服药物的副作用最小的替代药物。补骨脂素是从中草药中提取的香豆素衍生物。然而,补骨脂素在成骨细胞功能中的作用及其分子机制尚不清楚。本研究发现,补骨脂素通过上调成骨细胞特异性标志基因(包括icollagen,骨钙素和骨唾液蛋白)的表达,增强碱性磷酸酶的活性,以剂量依赖的方式促进小鼠原代成骨细胞的成骨分化。本研究同时证明补骨脂素能上调BMP2和BMP4基因的表达,提高磷酸化smad1/5/8蛋白水平,激活BMP报告基因(12xbe-oc-luc)的活性以及增强BMP信号直接靶基因osx的表达。BMP2和BMP4基因的缺失消除了补骨脂素对成骨细胞标志基因col1、alp、oc和bsp表达的促进作用。结果表明,补骨脂素通过激活BMP信号促进成骨细胞分化,提示补骨脂素可能是治疗骨质疏松等骨丢失相关疾病的一种潜在的合成代谢剂。     

中药美白成分的复配及复方中药发酵液的功效

【目的】通过中药美白成分的复配,进而研究复方中药发酵液活性成分及功效性。【方法】以酪氨酸酶抑制率为指标研究最佳复配含量,采用分光光度法测定复方中药发酵液中总酚、多糖、黄酮、蛋白质含量,通过HPLC技术进行氨基酸分析,抗氧化能力通过总还原力和自由基清除试验进行评价,通过酪氨酸酶活性抑制实验进行美白功效分析。【结果】正交实验得出4种中药美白成分中覆盆子对酪氨酸酶抑制效果最好;复方中药发酵液中多酚、多糖、黄酮和蛋白质含量分别为147.80、4.36、1.17、2.22 g/kg;复方中药发酵液具有较高的总还原力、羟自由基清除能力和DPPH自由基清除能力;5%(W/V)复方中药发酵液的酪氨酸酶活性抑制率为82.41%。【结论】复方中药发酵液中含有多种活性成分,具有一定的抗氧化和美白功效。     

一种新型补骨脂素衍生物BSP-1诱导B16细胞中黑色素合成的作用机制

8-甲氧基补骨脂素（8-MOP）和5-甲氧基补骨脂素（5-MOP）等补骨脂素类药物在临床上常用于治疗白癜风,但同时具有诸多副作用。因此,发掘作用更强、毒性更小的补骨脂素类化合物用以治疗白癜风成为研究热点。在我们的前期研究中,本课题组设计合成了一系列结构新颖的补骨脂素席夫碱衍生物,并评价了它们的抗白癜风活性。本论文选取了其中一个补骨脂素席夫碱衍生物（BSP-1）,研究了它对小鼠B16细胞中黑色素合成的作用及其信号通路。利用CCK 法、L-Dopa 氧化法、NaOH溶解法及Western印迹法分别分析BSP-1对细胞增殖、黑色素含量、酪氨酸酶(TYR)活性及相关蛋白表达的影响。结果显示,BSP-1能够促进B16细胞内黑色素生成和TYR活性,上调 TYR、TRP-1、TRP-2和MITF的蛋白表达,并呈浓度依赖性。机制研究发现,BSP-1通过提高Akt和GSK-3β的磷酸化水平,上调细胞核中β 联蛋白的含量,最终使得小眼相关转录因子（MITF）的蛋白表达增加。综上所述,本研究提示BSP-1可通过调节Wnt/β-联蛋白信号通路来促进B16细胞内的黑色素合成。     

异补骨脂素加锌对大鼠成骨细胞增殖与分化的影响

为探讨异补骨脂素加锌对体外培养新生大鼠颅骨成骨细胞增殖与分化作用的影响,用改良的组织块培养法分离培养新生大鼠颅骨成骨细胞,在成骨细胞体系中以不同浓度加入异补骨脂素与锌,MTT法检测加药后不同时间成骨细胞的增殖情况;用对硝基苯二钠基质动力学法(PNPP)测定细胞内碱性磷酸酶的活性,用改良的Lowry法测蛋白含量.结果显示:异补骨脂素加锌较单纯应用异补骨脂素或硫酸锌在24和48 h时促体外大鼠成骨细胞增殖的作用更加明显;在48和72 h时能促进成骨细胞碱性磷酸酶活性(ALP),其中ALP的测定在72h的活性更为显著.与单纯应用异补骨脂素或者锌相比,异补骨脂素与锌联合应用能够协同增效,对体外培养的成骨细胞的增殖与分化作用更加显著.     

盐生植物盐地碱蓬酪氨酸酶的酶学特性

酪氨酸酶是植物甜菜素生物合成的限速酶,但是,其酶学特性尚不了解。以黑暗培养3d的盐地碱蓬幼苗为材料,采用NaF抽提、饱和硫酸铵沉淀法提取盐地碱蓬中的酪氨酸酶,以研究其酶学特性。结果表明,酪氨酸酶氧化活性的最适温度为35℃,最适pH值为6.6,最适条件下Km=1.09mmol·L-1,Vmax=71.43μmol·g-1（FW）·min-1;酪氨酸酶羟化活性的最适温度为40℃,最适pH值为6.6,最适条件下Km=3.16mmol·L-1,Vmax=0.645μmol·g-1（FW）·min-1。Na2S2O3是盐地碱蓬酪氨酸酶的强效抑制剂,0.05mol·L-1Na2S2O3几乎完全抑制酪氨酸酶氧化及羟化活性。而0.01mmol·L-1的Cu2＋可以显著激活酪氨酸酶的氧化及羟化活性,分别为对照的126%和128.2%。这些结果表明盐地碱蓬中酪氨酸酶的羟化活性是影响甜菜红素合成速率的关键,也为深入研究盐地碱蓬酪氨酸酶在甜菜素合成中的作用及其与环境之间的关系奠定了基础。     

Effect of Different Isomers of Dihydroxybenzoic Acids (DBA) on the Rate of DL-DOPA Oxidation by Mushroom Tyrosinase

Dihydroxybenzoic acids (DBA), such as 3,4-DRA, 3,5-DBA, and 2,4-DBA—at all concentrations tested—inhibited the rate of DL-DOPA oxidation to dopachrome (λmax = 475 nm) by mushroom tyrosinase. 2,3-DBA and 2,5-DBA at relatively low concentration had a synergistic effect on the reaction, whereas at relatively high concentrations they inhibited the rate of DL-DOPA oxidation. The synergistic effect of 0.6-13.3 mM 2,3-DRA on the rate of DL-DOPA oxidation to dopachrome (λmax = 475 nm) was found to be due to the ability of 2,3-DBA-o-quinone (formed by the oxidation of 2,3-DBA by mushroom tyrosinase or by sodium periodate) to oxidize DL-DOPA to dopachrome (via dopaquinone) non-enzymatically. A similar explanation is likely to be valid for the synergism exerted by 2,5-DBA on the rate of DL-DOPA oxidation by mushroom tyrosinase.     

Effect of different isomers of dihydroxybenzoic acids (DBA) on the rate of DL-dopa oxidation by mushroom tyrosinase.

Dihydroxybenzoic acids (DBA), such as 3,4-DBA, 3,5-DBA, and 2,4-DBA--at all concentrations tested--inhibited the rate of DL-DOPA oxidation to dopachrome (lambda max = 475 nm) by mushroom tyro0sinase. 2,3-DBA and 2,5-DBA at relatively low concentration had a synergistic effect on the reaction, whereas at relatively high concentrations they inhibited the rate of DL-DOPA oxidation. The synergistic effect of 0.6-13.3 mM 2,3-DBA on the rate of DL-DOPA oxidation to dopachrome (lambda max = 475 nm) was found to be due to the ability of 2,3-DBA-o-quinone (formed by the oxidation of 2,3-DBA by mushroom tyrosinase or by sodium periodate) to oxidize DL-DOPA to dopachrome (via dopaquinone) non-enzymatically. A similar explanation is likely to be valid for the synergism exerted by 2,5-DBA on the rate of DL-DOPA oxidation by mushroom tyrosinase.     

The reaction of alpha-synuclein with tyrosinase: possible implications for Parkinson disease

Oxidative stress appears to be directly involved in the pathogenesis of Parkinson disease. Several different pathways have been identified for the production of oxidative stress conditions in nigral dopaminergic neurons, including a pathological accumulation of cytosolic dopamine with the subsequent production of toxic reactive oxygen species or the formation of highly reactive quinone species. On these premises, tyrosinase, a key copper enzyme known for its role in the synthesis of melanin in skin and hair, has been proposed to take part in the oxidative chemistry related to Parkinson disease. A study is herein presented of the in vitro reactivity of tyrosinase with alpha-synuclein, aimed at defining the molecular basis of their synergistic toxic effect. The results presented here indicate that, in conformity with the stringent specificity of tyrosinase, the exposed tyrosine side-chains are the reactive centers of alpha-synuclein. The reactivity of alpha-synuclein depends on whether it is free or membrane bound, and the chemical modifications on the tyrosinase-treated alpha-synuclein strongly influence its aggregation properties. On the basis of our results, we propose a cytotoxic model which includes a possible new toxic role for alpha-synuclein exacerbated by its direct chemical modification by tyrosinase.     

Synergism Exerted by 4-Methyl Catechol,Catechol, and Their Respective Quinones on the Rate of DL-DOPA Oxidation by Mushroom Tyrosinase

4-Methyl catechol and catechol, at concentrations ranging from 0.03 to 9 mM and 0.066 to 20 mM, respectively, have a synergistic effect on the rate of DL-DOPA oxidation by mushroom tyrosinase to material absorbing at 475 nm. The synergism results from the ability of 4-methyl catechol-o-quinone (4-methyl-o-benzoquinone) and of catechol-o-quinone (o-benzoquinone) to oxidize DL-DOPA non-enzymatically to dopaquinone, with the latter being immediately converted to dopachrome (λmax = 475 nm).     

Vitiligo,Psoralen, and Melanogenesis: Some Observations and Understanding

Since the etiology of vitiligo is still unknown, we searched for some abnormal biochemical parameters, if any, in subjects with vitiligo. Higher urinary excretion of indole metabolites in vitiliginous patients have been noted, in association with higher dioxygenase, superoxide dismutase, and tyrosine aminotransferase activity in their serum. Similar results have also been found in an animal model, Bufo melanostictus, during induced tyrosinase inhibition. Treatment with psoralen can reverse the parameters, except tyrosine aminotransferase, to a normal level. Although psoralens are not the magic bullet for the therapy of vitiligo, they are still being used as a chemotherapeutic agent against vitiligo on a major scale to date. Tryptophan was found to participate in the pathway of melanogenesis, as a precursor as well as a positive regulator of tyrosinase. Its behavior in this regard is much more similar to the conventional substrates tyrosine and dopa (dihydroxyphenylalanine). In consideration of combined participation of tyrosine and tryptophan in the synthesis of melanin and its breakdown, the possible influence of different enzymatic reactions, like mono-oxygenase, dioxygenase, and deamination, has been suggested.     

Synergism exerted by 4-methyl catechol, catechol, and their respective quinones on the rate of DL-DOPA oxidation by mushroom tyrosinase.

4-Methyl catechol and catechol, at concentrations ranging from 0.03 to 9 mM and 0.066 to 20 mM, respectively, have a synergistic effect on the rate of DL-DOPA oxidation by mushroom tyrosinase to material absorbing at 475 nm. The synergism results from the ability of 4-methyl catechol-o-quinone (4-methyl-o-benzoquinone) and of catechol-o-quinone (o-benzoquinone) to oxidize DL-DOPA non-enzymatically to dopaquinone, with the later being immediately converted to dopachrome (lambda max = 475 nm).     

Hypopigmenting agents: an updated review on biological, chemical and clinical aspects

An overview of agents causing hypopigmentation in human skin is presented. The review is organized to put forward groups of biological and chemical agents. Their mechanisms of action cover (i) tyrosinase inhibition, maturation and enhancement of its degradation; (ii) Mitf inhibition; (iii) downregulation of MC1R activity; (iv) interference with melanosome maturation and transfer; (v) melanocyte loss, desquamation and chemical peeling. Tyrosinase inhibition is the most common approach to achieve skin hypopigmentation as this enzyme catalyses the rate-limiting step of pigmentation. Despite the large number of tyrosinase inhibitors in vitro, only a few are able to induce effects in clinical trials. The gap between in-vitro and in-vivo studies suggests that innovative strategies are needed for validating their efficacy and safety. Successful treatments need the combination of two or more agents acting on different mechanisms to achieve a synergistic effect. In addition to tyrosinase inhibition, other parameters related to cytotoxicity, solubility, cutaneous absorption, penetration and stability of the agents should be considered. The screening test system is also very important as keratinocytes play an active role in modulating melanogenesis within melanocytes. Mammalian skin or at least keratinocytes/melanocytes co-cultures should be preferred rather than pure melanocyte cultures or soluble tyrosinase.     

Cinnamic acid 4-hydroxylase mechanism-based inactivation by psoralen derivatives: cloning and characterization of a C4H from a psoralen producing plant-Ruta graveolens-exhibiting low sensitivity to psoralen inactivation

Cinnamate 4-hydroxylase (C4H, EC 1.14.13.11) complete cDNA was cloned from the leaves of Ruta graveolens, a psoralen producing plant. The recombinant enzyme (classified CYP73A32) was expressed in Saccharomyces cerevisiae. Mechanism-based inactivation was investigated using various psoralen derivatives. Only psoralen and 8-methoxypsoralen were found to inactivate C4H. The inactivation was dependent on the presence of NADPH, time of pre-incubation, and inhibitor concentration. Inactivation stoichiometry was 0.9 (+/-0.2) for CYP73A1 and 1.1 (+/-0.2) for CYP73A32. SDS-PAGE analysis demonstrated that [3H]psoralen was irreversibly bound to the C4H apoprotein. K(i) and k(inact) for psoralen and 8-methoxypsoralen inactivation on the two C4H revealed a lower sensitivity for CYP73A32 compared to CYP73A1. Inactivation kinetics were also determined for CYP73A10, a C4H from another furocoumarin-producing plant, Petroselinum crispum. This enzyme was found to behave like CYP73A32, with a weak sensitivity to psoralen and 8-MOP inactivation. Cinnamic acid hydroxylation is a key step in the biosynthesis of phenylpropanoid compounds, psoralen derivatives included. Our results suggest a possible evolution of R. graveolens and P. crispum C4H that might tolerate substantial levels of psoralen derivatives in the cytoplasmic compartment without a depletive effect on C4H and the general phenylpropanoid metabolism.     

Oligosaccharide trimming plays a role in the endoplasmic reticulum-associated degradation of tyrosinase

The effect of glucosidase and mannosidase inhibitors on the ER-associated degradation of tyrosinase was assessed in transiently transfected COS-7 cells. We found that the glucosidase inhibitors castanospermine and deoxynojirimycin had very little effect on tyrosinase degradation, whereas the mannosidase inhibitors deoxymannojirimycin and kifunensine significantly delayed the rate of tyrosinase degradation as measured by pulse-chase analysis. In addition, we show that tyrosinase degradation is sensitive to the proteasome inhibitor lactacystin and that tyrosinase associates with endogenous calnexin in COS-7 cells. Our data support a model of tyrosinase degradation that involves mannose trimming, calnexin association, and the retrograde transport of tyrosinase from the ER to the cytosol for proteasomal degradation. The pathways of tyrosinase degradation have important ramifications with regard to the exact types of antigenic epitopes that are presented to the immune system.